Ultrastructural and metabolic changes in the neuropeptide Y-containing striatal neuronal network after thermocoagulatory cortical lesion in adult rat

Synapse

Volumn 34, Issue 3, 1999, Pages 208-221

  Kachidian, Philippe ^a   Vuillet, Jacqueline ^a,b   Salin, Pascal ^a   Kerkerian Le Goff, Lydia ^a  

^a CNRS   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Corticostriatal pathway; Excitatory amino acid; Striatum; Synaptic plasticity

Indexed keywords

EXCITATORY AMINO ACID; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX LESION; BRAIN METABOLISM; CELL DENSITY; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; THERMOCOAGULATION; ULTRASTRUCTURE;

ANIMALS; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON; NEOSTRIATUM; NEURONS; NEUROPEPTIDE Y; RATS; RATS, WISTAR; SYNAPSES; TIME FACTORS;

EID: 0032756862     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19991201)34:3<208::AID-SYN5>3.0.CO;2-6     Document Type: Article

References (66)

1. Adrian TE, Allen JM, Bloom SR, Ghatei MA, Rossor MN, Roberts, GW, Crow TJ, Tatemoto K, Polak JM. 1983. Neuropeptide Y distribution in human brain. Nature (Lond) 306:584-586.
2. Allen YS, Adrian TE, Allen JM, Tatemoto K, Crow TJ, Bloom SR, Polak JM. 1983. Neuropeptide Y distribution in the rat brain. Science 221:877-879.
3. Augood SJ, McGowan EM, Emson PC. 1994. Expression of N-methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells. Neuroscience 59:7-12.
4. Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ, Martin JB. 1986. Replication of the neurochemical characteristics of Hunn tington's disease by quinolinic acid. Nature (Lond) 321:168-171.
5. Beal MF, Mazurek MF, Elison DW, Swartz KJ, McGarvey U, Bird ED, Martin JB. 1988. Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease. Ann Neurol 23:562-569.
6. Beal MF, Kowall NW, Swartz KJ, Ferrante RJ. 1990. Homocysteic acid lesions in rat striatum spare somatostatin-neuropeptide Y (NADPH-diaphorase) neurons. Neurosci Lett 108:36-42.
7. Beal MF, Ferrante RJ, Swartz KJ, Kowall NW. 1991. Chronic quinon linic acid lesions in rats closely resemble Huntington's disease. J Neurosci 11:1649-1659.
8. Bernard V, Somogyi P, Bolam JP. 1997. Cellular, subcellular, and subsynaptic distributions of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci 17:819-833.
9. Boegman RJ, Parent A. 1988. The response of striatal neuropeptide Y and cholinergic neurons to excitatory amino acid agonists. Brain Res 452:219-226.
10. Bredt DS, Snyder SH. 1992. Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
11. Burke RE, Kenyon N. 1991. The effect of neonatal hypoxia-ischemia on striatal cholinergic neuropil: A quantitative morphologic analysis. Exp Neurol 113:63-73.
12. Calabresi P, Pisani A, Mercuri NB, Bernardi G. 1996. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci 19:19-24.
13. Catania MV, Tölle TR, Monyer H. 1995. Differential expression of AMPA receptor subunits in NOS-positive neurons of cortex, striatum, and hippocampus. J Neurosci 15:7046-7061.
14. Chen Q, Veenman CL, Reiner A. 1996. Cellular expression of ionotropic glutamate receptor subunits on specific striatal neuron types and its implication for striatal vulnerability in glutamate receptor-mediated excitotoxicity. Neuroscience 73:715-731.
15. Cudkowicz M, Kowall NW. 1990. Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 27:200-204.
16. Dawbarn D, De Quidt ME, Emson PC. 1985. Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease. Brain Res 340:251-260.
17. Dawson, TM, Bredt DS, Fotuhi M, Hwang PM, Snyder SH. 1991. Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues. Proc Natl Acad Sci USA 88:7797-7801.
18. De Quidt ME, Emson PC. 1986. Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system: II. Immunohistochemical analysis. Neuroscience 18:545-618.
19. Divac I, Fonnum F, Storm-Mathisen J. 1977. High affinity uptake of glutamate in terminals of corticostriatal axons. Nature (Lond) 266:377-378.
20. Dubé L, Smith AD, Bolam JP. 1988. Identification of synaptic terminals of thalamic or cortical origin in contact with distinct medium-size spiny neurons in the rat neostriatum. J Comp Neurol 267:455-471.
21. 3H)glutamic acid binding to rat striatal membranes. II. Effects of selective striatal lesions and deafferentations. Brain Res 366:178-186.
22. Figueredo-Cardenas G, Morello M, Sancesario G, Bernardi G, Reiner A. 1996. Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats. Brain Res 735:317-324.
23. Figueredo-Cardenas G, Chen Q, Reiner A. 1997. Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats. Exp Neurol 146:444-457.
24. Fonnum FF, Storm-Mathisen J, Divac I. 1981. Biochemical evidence for glutamate as the neurotransmitter in corticostriatal and cortico-thalamic fibres in rat brain. Neuroscience 6:863-873.
25. Garside S, Mazurek MF. 1997. Role of glutamate receptor subtypes in the differential release of somatostatin, neuropeptide Y, and substance P in primary serum-free cultures of striatal neurons. Synapse 27:161-167.
26. Godukhin OV, Zharikova AD, Novoselov VI. 1980. The release of labelled L-glutamic acid from rat neostriatum in vivo following stimulation of frontal cortex. Neuroscience 5:2151-2154.
27. Graybiel AM, Ragsdale CW Jr. 1979. Fiber connections of the basal ganglia. Prog Brain Res 51:239-283.
28. Hassler R, Haug P, Nitsch C, Kim JS, Paik K. 1982. Effects of motor and premotor cortex ablations on concentrations of amino acids, monoamines and acetylcholine and on the ultrastructure in rat striatum. A confirmation of glutamate as the specific corticostriatal transmitter. J Neurochem 38:1087-1098.
29. Hayden MR. 1981. Huntington's chorea. New York: Springer.
30. Ingham CA, Hood SH, Arbuthnott GW. 1991. A light and electron microscopical study of enkephalin-immunoreactive structures in the rat neostriatum after removal of the nigrostriatal dopaminergic pathway. Neuroscience 42:715-730.
31. Kawaguchi Y, Wilson CJ, Augood SJ, Emson PC. 1995. Striatal interneurones: Chemical, physiological and morphological characterization. Trends Neurosci 18:527-535.
32. Kerkerian L, Salin P, Nieoullon A. 1990. Cortical regulation of striatal neuropeptide Y (NPY)-containing neurons in the rat. Putative modulatory influence on striatal dopamine-NPY relationships. Eur J Neurosci 2:181-189.
33. Kerkerian-Le Goff L, Forni C, Samuel D, Bloc A, Dusticier N, Nieoullon A. 1992. Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum. Brain Res Bull 28:187-193.
34. Kerns JM, Sierens DK, Kao LC, Klawans HL, Carvey PM. 1992. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 15:488-500.
35. Kocsis JD, Sugimori M, Kitai ST. 1977. Convergence of excitatory synaptic inputs to caudate spiny neurons. Brain Res 124:403-413.
36. Koh JY, Choi DW. 1988. Cultured striatal neurons containing NADPH-diaphorase or acetylcholinesterase are selectively resistant to injury by NMDA receptor agonists. Brain Res 446:374-378.
37. Kowall NW, Ferrante RJ, Beal MF, Richardson Jr. EP, Sofroniew MV, Cuello AC, Martin JB. 1987a. Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate-diaphorase in the human striatum: A combined immunocytochemical and enzyme histochemical study. Neuroscience 20:817-828.
38. Kowall NW, Ferrante RJ, Martin JB. 1987b. Patterns of cell loss in Huntington's disease. Trends Neurosci 10:24-29.
39. Landwehrmeyer GB, Standaert DG., Testa CM, Penney JB Jr., Young AB. 1995. NMDA receptor subunits mRNA expresion by projection neurons and interneurons in rat striatum. J. Neurosci 15:5297-5307.
40. Marshall PE., Landis DMD. 1985. Huntington's disease is accompanied by changes in the distribution of somatostatin-containing neuronal processes. Brain Res 329:71-82.
41. McGeer PL, Mc Geer EG, Scerer V, Singh K. 1977. A glutamatergic corticostriatal pathway. Brain Res 128:369-373.
42. McGeorge AJ, Faull RLM. 1989. The organization of the projection from the cerebral cortex to the striatum in the rat. Neuroscience 29:503-537.
43. Midgley LP, Bush LG, Gibb JW, Hanson GR. 1992. Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen. Brain Res 593:89-96.
44. Napieralski JA, Butler AK, Chesselet MF. 1996. Anatomical and functional evidence for lesion-specific sprouting of corticostriatal input in the adult rat. J Comp Neurol 373:484-497.
45. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates, 2nd ed. London: Academic Press.
46. Pettersson E, Herrera-Marschitz M, Rodriguez-Puertas R, Xu ZQ, You ZB, Hughes J, Elde RP, Ungerstedt U, Hökfelt T. 1996. Evidence for aspartate-immunoreactive neurons in the neostriatum of the rat: Modulation by the mesencephalic dopamine pathway via D1-subtype of receptor. Neuroscience 74:51-66.
47. Reubi JC, Cuénod M. 1979. Glutamate release in vitro from corticostriatal terminals. Brain Res 176:185-188.
48. Roberts RC, Ahn A, Swartz KJ, Beal MF, DiFiglia M. 1993. Intrastriatal injections of quinolinic acid or kainic acid: Differential patterns of cell survival and the effects of data analysis on outcome. Exp Neurol 124:274-282.
49. Rothe F, Wolf G. 1990. Changes in glutamate-related enzyme activities in the striatum of the rat following lesion of corticostriatal fibres. Exp Brain Res 79:400-404.
50. Rowlands G, Roberts PJ. 1980. Specific calcium dependent release of endogeneous glutamate from rat striatum is reduced by destruction of the corticostriatal tract. Exp Brain Res 39:239-248.
51. Salin P, Chesselet MF. 1990. Effects of Haloperidol and cortical lesions on the level of neuropeptide Y mRNA in the striatum of the rat: a study by in situ hybridization histochemistry. In Allen JM, Koenig JI, editors. Central and peripheral significance of neuropeptide Y and its related peptides. Ann NY Acad Sci 61:459-462.
52. Salin P, Chesselet MF. 1992. Paradoxical increase in striatal neuropeptide gene expression following ischemic lesions of the cerebral cortex. Proc Natl Acad Sci USA 89:9954-9958.
53. Salin P, Nieoullon A, Kerkerian-Le Goff L. 1994. Reversal of the adaptative response of neuropeptide Y neurons in the rat striatum to nigrostriatal dopamine deafferentation by the N-methyl-D-aspartate antagonist dizocilpine maleate. Neuroscience 61:93-105.
54. Salin P. Nieoullon A. 1996. The contralateral cortex contributes to the effects of hemidecortication on neuropeptide Y immunoreactivity in the rat striatum. Neurosci Lett 220:179-182.
55. Smith Y, Parent A. 1986. Neuropeptide Y-immunoreactive neurons in the striatum of cat and monkey: Morphological characteristics, intrinsic organization and co-localization with somatostatin. Brain Res 372:241-252.
56. Smith Y, Parent A, Kerkerian L, Pelletier G. 1985. Distribution of neuropeptide Y immunoreactivity in the basal forebrain and upper brainstem of the squirrel monkey (Saimiri Sciureus). J Comp Neurol 236:71-89.
57. Szele FG, Alexander C, Chesselet MF. 1995. Expression of molecules associated with neuronal plasticity in the striatum after aspiration and thermocoagulatory lesions of the cerebral cortex in adult rats. J Neurosci 15:4429-4448.
58. Tallaksen-Greene SJ, Albin RL 1994. Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons. Neuroscience 61:509-519.
59. Uhl GR, Navia B, Douglas J. 1990. Differential expresion of preproenkephalin and prepradynorphin mRNAs in striatal neurons: high levels of preproenkephalin expression depend on cerebral cortical afferents. J Neurosci 8:4755-4764.
60. Vacca LL, Rosario SL, Zimmerman EA, Tomashefsky F, Hsu KC. 1975. Application of immunoperoxidase techniques to localize horseradish peroxidase-tracer in the central nervous system. J Histochem Cytochem 23:208-215.
61. Vincent SR, Johansson O, Hökfelt T, Skirboll L, Elde RP, Terenius L, Kimmel J, Goldstein M. 1983. NADPH-diaphorase: A selective histochemical marker for striatal neurons containing both somatostatin- and avian pancreatic polypeptide (APP)-like immunoreactivities. J Comp Neurol 217:252-263.
62. Vonsattel JP, Meyers RH, Stevens TJ. 1985. Neuropathologic classification of Hungtington's disease. J Neuropathol Exp Neurol 44:559-577.
63. Vuillet J, Kerkerian L, Salin P, Nieoullon A. 1989a. Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Res 477:241-251.
64. Vuillet J, Kerkerian L, Salin P, Nieoullon A. 1989b. Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum. Neurosci Lett 100:99-104.
65. Vuillet J, Kerkerian-Le Goff L, Kachidian P, Dusticier G, Bosler O, Nieoullon A. 1990. Striatal NPY-containing neurons receive GABAergic afferents and may also contain GABA: An electron microscopic study in the rat. Eur J Neurosci 2:672-681.
66. Wilson CJ. 1986. Postsynaptic potentials evoked in spiny neostriatal projection neurons by stimulation of ipsilateral and contralateral neocortex. Brain Res 367:201-213.